SCHEMBL31108337

SCHEMBL31108337

Cc1c(NC(=O)c2ccc(C=O)cn2)cccc1-c1cccc(NC(=O)c2ccc(CN3CC4(CCOCC4)C3)cn2)c1Cl

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PDCD1 Q15116 20/20 0.51
▸ CD274 Q9NZQ7 20/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31108306 0.86 PDCD1 (0.52) PDCD1CD274
SCHEMBL31108286 0.85 PDCD1 (0.53) PDCD1CD274
SCHEMBL31108270 0.84 PDCD1 (0.57) PDCD1CD274
SCHEMBL31108290 0.83 PDCD1 (0.51) PDCD1CD274
SCHEMBL20293682 0.81 PDCD1 (0.57) PDCD1CD274
SCHEMBL20293707 0.81 PDCD1 (0.63) PDCD1CD274
SCHEMBL20293705 0.81 PDCD1 (0.63) PDCD1CD274
SCHEMBL20305010 0.81 PDCD1 (0.63) PDCD1CD274
SCHEMBL31108331 0.80 PDCD1 (0.62) PDCD1CD274
SCHEMBL31108244 0.79 CD274 (0.63) PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4694981-A1 HETEROCYCLIC COMPOUNDS AS DUAL INHIBITORS OF PD-L1 AND ADENOSINE RECEPTORS Aurigene Oncology Limited (IN) 2026-02-18 — — EP disclosed
WO-2024214088-A1 HETEROCYCLIC COMPOUNDS AS DUAL INHIBITORS OF PD-L1 AND ADENOSINE RECEPTORS AURIGENE ONCOLOGY LIMITED (IN) 2024-10-17 — — WO disclosed
Send feedback